CoChat

The Effect of the Cholinergic Anti‐Inflammatory Pathway on Experimental Colitis

Open access
Bai, A., Guo, Y., Lu, N. · 2007 · Scandinavian Journal of Immunology
Cited by 72

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Inflammatory bowel diseases (IBD) are characterized by proinflammatory cytokines, tissue damage and loss of neuron in inflamed mucosa, which implies the cholinergic anti‐inflammatory pathway may be destroyed during the process of inflammatory response. In the study, we identified the effect of cholinergic agonist as anabaseine (AN) and nicotinic receptor antagonist as chlorisondamine diiodide (CHD) on trinitrobenzene sulfonic acid (TNBS)‐induced colitis, to investigate the potential therapeutic effect of the cholinergic anti‐inflammatory pathway on IBD. Experimental colitis was induced by TNBS at day 1, 10 μg AN or 1.5 μg CHD was injected i.p. to mouse right after the induction of colitis, and repeated on interval day till the mice were sacrificed at day 8. Colonic inflammation was examined by histological analysis, myeloperoxidase (MPO) activity, and the production of tumour necrosis factor (TNF)‐α in tissue. Lamina propria mononuclear cells (LPMC) were isolated, and NF‐κB activation was detected by western blot. The mice with colitis treated by AN showed less tissue damage, less MPO activity, less TNF‐α production in colon, and inhibited NF‐κB activation in LPMC, compared with those mice with colitis untreated, whereas the mice with colitis treated by CHD showed the worst tissue damage, the highest MPO activity, the highest TNF‐α level, and enlarged NF‐κB activation in LPMC. Agonist of the cholinergic anti‐inflammatory pathway inhibits colonic inflammatory response by downregulating the production of TNF‐α, and inhibiting NF‐κB activation, which suggests that modulating the cholinergic anti‐inflammatory pathway may be a new potential management for IBD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-3083.2007.02011.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 72

Metadata

Authors
Bai, A., Guo, Y., & Lu, N.
Venue
Scandinavian Journal of Immunology
Publisher
Wiley
Published
2007-10-17
Volume
66
Issue
5
Pages
538-545
ISSN
  • 0300-9475 (ISSN-L)
  • 1365-3083
OpenAlex
W2040557082
Cited by
72
References
8
FWCI
1.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.